The Class II recall covers 3 dosage strengths made by Actavis for Teva; patients are warned against stopping the patches without consulting a doctor ...
The once-daily GLP-1 pill cut blood sugar more than insulin and shed 17.9 pounds on average -- Lilly plans to file for FDA diabetes approval by end of Q2 ...